93 related articles for article (PubMed ID: 11095588)
1. Disposition and alpha(1)-adrenoceptor binding characteristics of JTH-601 and its metabolites in rat tissues.
Yamada S; Okura T; Kimura R; Deguchi Y; Suzuki Y; Kobayashi T; Aisaka K
Drug Metab Dispos; 2000 Dec; 28(12):1487-92. PubMed ID: 11095588
[TBL] [Abstract][Full Text] [Related]
2. In vivo measurement by [3H]Tamsulosin of alpha1 adrenoceptors in rat tissues in relation to the pharmacokinetics.
Yamada S; Ohkura T; Deguchi Y; Kimura R
J Pharmacol Exp Ther; 1999 Jun; 289(3):1575-83. PubMed ID: 10336555
[TBL] [Abstract][Full Text] [Related]
3. In vivo demonstration of alpha(1A)-adrenoceptor subtype selectivity of KMD-3213 in rat tissues.
Yamada S; Okura T; Kimura R
J Pharmacol Exp Ther; 2001 Jan; 296(1):160-7. PubMed ID: 11123376
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo and in vivo alpha1-adrenoceptor binding characteristics of a novel alpha1L-adrenoceptor antagonist, JTH-601, in rat tissues.
Ohkura T; Yamada S; Tohma A; Kimura R; Aisaka K
Biol Pharm Bull; 1999 Jul; 22(7):687-90. PubMed ID: 10443463
[TBL] [Abstract][Full Text] [Related]
5. New alpha1-adrenoceptor antagonist, JTH-601, shows more than 10 times higher affinity for human prostates than arteries.
Takahashi M; Taniguchi T; Murata S; Okada K; Moriyama N; Yamazaki S; Muramatsu I
J Urol; 1999 Apr; 161(4):1350-4. PubMed ID: 10081906
[TBL] [Abstract][Full Text] [Related]
6. In vivo receptor binding of novel alpha1-adrenoceptor antagonists for treatment of benign prostatic hyperplasia.
Yamada S; Ohkura T; Kimura R; Kawabe K
Life Sci; 1998; 62(17-18):1585-9. PubMed ID: 9585140
[TBL] [Abstract][Full Text] [Related]
7. RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.
Nanda K; Naruganahalli KS; Gupta S; Malhotra S; Tiwari A; Hegde LG; Jain S; Sinha N; Gupta JB; Chugh A; Anand N; Ray A
Eur J Pharmacol; 2009 Apr; 607(1-3):213-9. PubMed ID: 19239913
[TBL] [Abstract][Full Text] [Related]
8. The effects of tamsulosin, a high affinity antagonist at functional alpha 1A- and alpha 1D-adrenoceptor subtypes.
Noble AJ; Chess-Williams R; Couldwell C; Furukawa K; Uchyiuma T; Korstanje C; Chapple CR
Br J Pharmacol; 1997 Jan; 120(2):231-8. PubMed ID: 9117115
[TBL] [Abstract][Full Text] [Related]
9. Effects of tamsulosin metabolites at alpha-1 adrenoceptor subtypes.
Taguchi K; Saitoh M; Sato S; Asano M; Michel MC
J Pharmacol Exp Ther; 1997 Jan; 280(1):1-5. PubMed ID: 8996174
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo occupancy by tamsulosin of alpha1-adrenoceptors in rat tissues in relation to the plasma concentration.
Ohkura T; Yamada S; Deguchi Y; Kimura R; Matsushima H; Higuchi S; Inagaki O; Honda K; Takenaka T
Life Sci; 1998; 63(24):2147-55. PubMed ID: 9851306
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of [3H]-JTH-601, a novel alpha1-adrenoceptor antagonist: binding to recombinant human alpha1-adrenoceptors and human prostates.
Takahashi M; Taniguchi T; Kanamaru H; Okada K; Muramatsu I
Life Sci; 2000 Oct; 67(20):2443-51. PubMed ID: 11065167
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part I.
Leonardi A; Hieble JP; Guarneri L; Naselsky DP; Poggesi E; Sironi G; Sulpizio AC; Testa R
J Pharmacol Exp Ther; 1997 Jun; 281(3):1272-83. PubMed ID: 9190863
[TBL] [Abstract][Full Text] [Related]
13. Prostate selectivity of JTH-601-G1, an active metabolite of JTH-601, in dogs.
Suzuki Y; Kanada A; Okaya Y; Kurahashi Y; Kogayu M; Kobayashi T; Aisaka K
BJU Int; 2000 Mar; 85(4):542-50. PubMed ID: 10691841
[TBL] [Abstract][Full Text] [Related]
14. Effect of JTH-601, a novel alpha1-adrenoceptor antagonist, on the function of lower urinary tract and blood pressure.
Suzuki Y; Kanada A; Okaya Y; Aisaka K; Muramatsu I
Eur J Pharmacol; 1999 Jun; 374(3):495-502. PubMed ID: 10422795
[TBL] [Abstract][Full Text] [Related]
15. Effect of JTH-601, a novel alpha(1)-adrenoceptor antagonist, on prostate function in dogs.
Suzuki Y; Kanada A; Okaya Y; Aisaka K
Eur J Pharmacol; 2000 Apr; 394(1):123-30. PubMed ID: 10771044
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of buflomedil on prostate alpha1A adrenoceptor in the Wistar rat.
Tang LM; Cheng JT; Tong YC
Neurosci Lett; 2004 Sep; 367(2):224-7. PubMed ID: 15331158
[TBL] [Abstract][Full Text] [Related]
17. Selective and sustained occupancy of prostatic alpha1-adrenoceptors by oral administration of KMD-3213 and its plasma concentration in rats.
Okura T; Yamada S; Abe Y; Kimura R
J Pharm Pharmacol; 2002 Jul; 54(7):975-82. PubMed ID: 12162717
[TBL] [Abstract][Full Text] [Related]
18. Comparative study on pharmacokinetics and in vivo alpha1-adrenoceptor binding of [3H]tamsulosin and [3H]prazosin in rats.
Ohkura T; Yamada S; Deguchi Y; Kimura R
Biol Pharm Bull; 1999 Apr; 22(4):412-7. PubMed ID: 10328564
[TBL] [Abstract][Full Text] [Related]
19. Distribution of alpha1L-adrenoceptors in canine prostate: characterization by quantitative autoradiography.
Suzuki Y; Moriyama N; Okaya Y; Kanada A; Nishimatsu H; Kawabe K; Aisaka K
J Pharm Pharmacol; 2000 Jun; 52(6):653-7. PubMed ID: 10875541
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization and autoradiographic distribution of alpha2-adrenoceptor antagonist [3H]RX 821002 binding sites in the chicken brain.
Díez-Alarcia R; Pilar-Cuéllar F; Paniagua MA; Meana JJ; Fernández-López A
Neuroscience; 2006 Aug; 141(1):357-69. PubMed ID: 16697114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
